KURA Earnings

KURA reported its earnings on 2026-05-12, showcasing a revenue of against an estimate of 15.06M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.88 by 0%. The stock experienced a 0.91% price change on the earnings day and a 6.17% change over the next five days, reflecting market reactions to the results.

Following KURA's earnings announcement on 2026-05-12, the stock price moved by 0.91% on the day of the release. Over the subsequent five days, it saw a 6.17% change. Historically, KURA's stock price tends to shift by an average of -2.09% in the 10 days leading up to earnings and 4.64% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate KURA's annual revenue to reach 28.69M, while the EPS is projected at -0.81. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between KURA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, KURA's stock price typically moves by -2.09% in the 10 days before its earnings and 4.64% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.81 and revenue of 28.69M.

The earnings call summary reveals strong financial performance, strategic product development, and a solid market strategy, particularly with the KOMZIFTI product showing strong momentum. The Q&A section further highlights the positive reception of KOMZIFTI, its combination use, and strong patient start metrics, reinforcing the positive outlook. The strategic plan and market opportunity also suggest a favorable long-term growth trajectory. Despite some uncertainty in management's responses, the overall sentiment remains positive, suggesting a stock price increase of 2% to 8% over the next two weeks.